{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:36:17Z","timestamp":1793500577716,"version":"4.5.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Adult-onset immunodeficiency associated with anti-interferon-\u03b3 (IFN-\u03b3) autoantibodies (AIGA) is a rare immune disorder that neutralizes IFN-\u03b3 activity and compromises defense against intracellular pathogens. It is predominantly reported in Southeast Asia and predisposes affected individuals to recurrent and multiple intracellular bacterial infections, which can be life-threatening. As a \u201csilent disruptor,\u201c AIGA often go unnoticed due to their insidious nature, leading to a lack of sufficient clinical awareness. This report presents the case of a 59-year-old male patient from Wenzhou, Zhejiang Province, China, who experienced multiple severe infections over one year. These included disseminated bloodstream infection caused by\n                    <jats:italic>Salmonella enteritidis<\/jats:italic>\n                    , pneumonia caused by\n                    <jats:italic>Legionella pneumophila<\/jats:italic>\n                    , and osteomyelitis (an infection of bone and bone marrow caused by microbial pathogens) of the right scapula caused by\n                    <jats:italic>Talaromyces marneffei<\/jats:italic>\n                    , which are rarely observed consecutively in immunocompetent individuals. The patient exhibited no distinct immune phenotypic abnormalities, leading to the insidious nature of the disease. After receiving short-term targeted antimicrobial therapy, long-term rituximab treatment and prophylactic anti-infective therapy, the patient eventually recovered and was discharged, with regular follow-up to monitor AIGA titers. This case suggests that AIGA\u2013associated immunodeficiency should be considered in adults presenting with unexplained or recurrent intracellular infections, even when their immunophenotypic features appear unremarkable. Prompt detection of AIGA is essential for establishing an accurate diagnosis and initiating appropriate treatment. Immunomodulatory therapy with rituximab, in combination with targeted antimicrobial therapy and close long-term follow-up, can achieve favorable clinical outcomes. Ongoing clinical experience and research are needed to establish standardized therapeutic strategies and determine the optimal treatment duration for this rare immunodeficiency.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1840699","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:57:07Z","timestamp":1778651827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti\u2013interferon-\u03b3 autoantibody\u2013associated adult-onset immunodeficiency with occult immunological abnormalities and sequential intracellular infections: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiran","family":"Zhou","sequence":"first","affiliation":[{"name":"Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panjie","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Life Science, Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine and Life Science, Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieli","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University","place":["Wenzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/mop.0000000000001331","article-title":"Clinical updates in inborn errors of immunity: a focus on the noninfectious clinical manifestations","volume":"36","author":"Campbell","year":"2024","journal-title":"Curr Opin Pediatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-\u03b3 immunity against Mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01905","article-title":"Neutralizing activity of anti-interferon-\u03b3 autoantibodies in adult-onset immunodeficiency is associated with their binding domains","volume":"10","author":"Yasamut","year":"2019","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/ijms25010515","article-title":"Anticytokine autoantibodies in infectious diseases: a practical overview","volume":"25","author":"Arts","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051673","article-title":"Pathogen spectrum and immunotherapy in patients with anti-IFN-\u03b3 autoantibodies: a multicenter retrospective study and systematic review","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s312042","article-title":"Talaromyces marneffei and Burkholderia cepacia co-infection in a HIV-uninfected patient with anti-interferon-\u03b3 autoantibodies","volume":"14","author":"Zeng","year":"2021","journal-title":"Infect Drug Resist"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz208","article-title":"Characterization of anti-interferon-\u03b3 antibodies in HIV-negative patients infected with disseminated Talaromyces marneffei and cryptococcosis","volume":"6","author":"Zeng","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10875-025-01885-z","article-title":"Deepening understanding of the clinical features and diagnostic approaches to anti-interferon-gamma autoantibody associated adult-onset immunodeficiency in the last 20 years: a case report and literature review","volume":"45","author":"Zhao","year":"2025","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2210665","article-title":"Anti-interleukin-23 autoantibodies in adult-onset immunodeficiency","volume":"390","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad035","article-title":"Diagnostic and therapeutic challenges in disseminated Mycobacterium colombiense infection caused by interferon-\u03b3 neutralizing autoantibodies","volume":"10","author":"Matono","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1190631","article-title":"Stagnation arising through intermittent usage is associated with increased viable but non culturable Legionella and amoeba hosts in a hospital water system","volume":"13","author":"Nisar","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B15","unstructured":"WHO releases first-ever list of health-threatening fungi 25 October 2022"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112147-20240422-00214","article-title":"Mycobacterium tuberculosis infection complicated by talaromycosis in a patient with positive anti-interferon-\u03b3 autoantibodies: a case report","volume":"47","author":"Li","year":"2024","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e20190502","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-\u03b3 autoantibodies underlie disseminated Talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01423-1","article-title":"Distinct lymphocyte immunophenotyping and quantitative anti-interferon gamma autoantibodies in Taiwanese HIV-negative patients with non-tuberculous mycobacterial infections","volume":"43","author":"Lee","year":"2023","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12879-024-09003-x","article-title":"Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-\u03b3 autoantibodies: a case report","volume":"24","author":"Ning","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215581","article-title":"Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-\u03b3 autoantibodies","volume":"14","author":"Angkasekwinai","year":"2019","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/s41598-021-95686-0","article-title":"Talaromyces marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients","volume":"11","author":"Qiu","year":"2021","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01537-0","article-title":"Characteristics and outcomes of anti-interferon gamma antibody-associated adult onset immunodeficiency","volume":"43","author":"Zhang","year":"2023","journal-title":"J Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e36","article-title":"Increased inflammatory responses in patients with active disseminated non-tuberculous mycobacterial infection and high anti-interferon-gamma autoantibodies","volume":"24","author":"Srisai","year":"2024","journal-title":"Immune Netw"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12985-023-01989-1","article-title":"The detectable anti-interferon-\u03b3 autoantibodies in COVID-19 patients may be associated with disease severity","volume":"20","author":"Chen","year":"2023","journal-title":"Virol J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s364388","article-title":"Anti-interferon-\u03b3 autoantibodies impair T-lymphocyte responses in patients with Talaromyces marneffei infections","volume":"15","author":"Chen","year":"2022","journal-title":"Infect Drug Resist"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/qco.0000000000000561","article-title":"Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options","volume":"32","author":"Barcenas-Morales","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1038\/s41598-020-65933-x","article-title":"Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA","volume":"10","author":"Nithichanon","year":"2020","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad676","article-title":"Efficacy of Bortezomib for treating anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency syndrome","volume":"78","author":"Angkasekwinai","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw093","article-title":"Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-\u03b3 autoantibodies","volume":"3","author":"Pruetpongpun","year":"2016","journal-title":"Open Forum Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1840699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:57:12Z","timestamp":1778651832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1840699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2026.1840699"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1840699","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1840699"}}